Cargando…
Generation of insulin‐secreting organoids: a step toward engineering and transplanting the bioartificial pancreas
Diabetes is a major health issue of increasing prevalence. ß‐cell replacement, by pancreas or islet transplantation, is the only long‐term curative option for patients with insulin‐dependent diabetes. Despite good functional results, pancreas transplantation remains a major surgery with potentially...
Autores principales: | Wassmer, Charles‐Henri, Lebreton, Fanny, Bellofatto, Kevin, Bosco, Domenico, Berney, Thierry, Berishvili, Ekaterine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756715/ https://www.ncbi.nlm.nih.gov/pubmed/32852858 http://dx.doi.org/10.1111/tri.13721 |
Ejemplares similares
-
Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes
por: Lebreton, Fanny, et al.
Publicado: (2019) -
Author Correction: Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes
por: Lebreton, Fanny, et al.
Publicado: (2020) -
Biosynthetic Activity Differs Between Islet Cell Types and in Beta Cells Is Modulated by Glucose and Not by Secretion
por: Cottet-Dumoulin, David, et al.
Publicado: (2020) -
Bio-Engineering of Pre-Vascularized Islet Organoids for the Treatment of Type 1 Diabetes
por: Wassmer, Charles-Henri, et al.
Publicado: (2022) -
NLRP3 Inflammasome is Activated in Rat Pancreatic Islets by Transplantation and Hypoxia
por: Lavallard, Vanessa, et al.
Publicado: (2020)